Navigation Links
Medizone International's Mass-Market Sterilization Technology to be Produced by Canadian Medical Device Heavyweights
Date:1/19/2011

SAN FRANCISCO, Jan. 19, 2011 /PRNewswire/ -- Medizone International, Inc. (OTC Bulletin Board: MZEI) (OTCQB: MZEI) announced today that it has entered into a final product development and production agreement for the manufacture of its AsepticSure™ Advanced Oxidative Sterilization Processes, with ADA Innovations of Toronto, Canada.

Edwin Marshall, CEO of Medizone, commented, "Purely from a corporate perspective, ADA is a 'new kid on the block' - but what the development team behind it brings to the table for the future of AsepticSure™, exceeds all of our expectations."

ADA founders and directors, Mark Costa B.A. Sc Mechanical Engineering and Hao (Hawk) Chen M.S. Biomedical Engineering, bring more than 20 years of high-level experience to this project from the top echelons of industry – both in the engineering and medical device sectors.

Datascope Patient Monitoring (now Mindray North America), Husky, along with global medical device manufacturing giant, Mindray International, are just three of the big-name corporations on Mark and Hawk's respective resumes. Others of significance include; Vasogen and Hologic.

Marshall  commented, "After short-listing five potential manufacturing partners – each with impressive backgrounds in medical device development – ADA stood out as a logical choice for us, for two reasons: They were the only group who boasted a depth of knowledge in Ozone based technologies AND experience in medical device design, building and product launch."

Dr Michael Shannon, Medizone's Director of Medical affairs, added, "The dual qualifications that ADA brings to this collaborative venture are not only unique in the medical device industry, but are also essential to the achievement of our end-goal i.e. the mass production of a device that satisfies all design and operational requirements pertaining to any relevant market sector, anywhere on the planet."

Edwin Marshall went on to say, "ADA Innovations provides a perfect fit of knowledge, expertise and experience for bringing the AsepticSure™ systems to market."

"From a compliance point of view", said Marshall, "our relationship with ADA ensures that the design, content and manufacturing standards of the production units will be regulatory-compliant, not only in North America, but also in the lucrative UK and EU markets."

"Given that the stringent green regulations applicable to these two regions are some of the toughest in the world, it's reassuring to say the least," said Marshall, "that ADA can seamlessly tailor location-specific unit designs to meet and comply with local regulatory standards."

The AsepticSure™ final-phase development program, already underway, can be broken down into four primary, progressive steps as follows:

  • Completion of final commercial design and verification
  • Regional regulatory compliance
  • Soft product launch involving small scale manufacturing output
  • Multi-sector market penetration supported by up-scaled output and the ability to outsource macro manufacturing capacity at the appropriate time

  • "While the transition from beta to production equipment has taken significantly longer than anticipated a year ago, the 'wait', as they say, 'has been well worth it', said Marshall.  "We're now more confident than ever that our AsepticSure™ product line will far surpass any other form of sterilization technology on the market – not only in terms of its clinically proven anti-microbial efficacy, but also in its functionality, mobility and cost-effectiveness."For press information on Medizone, please contact:Jack Eversull, Investor Relations, The Eversull Group, Inc.T: 001-972-571-1624F: 001-214-469-2361E: jack@theeversullgroup.comMedizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, patient rooms, schools, clean rooms and other critical infrastructure. A government variant is being developed for bio-terrorism countermeasures with additional variants for sports facilities and food processing applications.

    This Press Release may contain certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues, the financial requirements of the company to achieve its business objectives, and the need for possible additional funding. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

    For more information, visit: www.medizoneint.com or email: operations@medizoneint.com


    '/>"/>
    SOURCE Medizone International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection
    2. Medizone International Announces Third Round of AsepticSure
    3. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
    4. Environmental Tectonics Corporations Sterilization Systems Group Awarded Major Contract
    5. Reportlinker Adds Global Sterilization Systems & Equipment Industry
    6. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
    7. Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective
    8. BeamOne LLC to Add New Ebeam Sterilization Service Center
    9. Zyga Technology, Inc. Receives FDA 510(K) Clearance for the SImmetry™ Sacroiliac Joint Fusion System
    10. Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
    11. Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwCs Medical Technology Innovation Scorecard
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/2/2017)... , Aug. 2, 2017 CaryRx, a next-generation ... day delivery service for patients in the Washington ... traditional retail pharmacy by providing delivery of medications through the ... for future delivery or delivered within one hour to any ... are excited to bring this invaluable service to ...
    (Date:7/31/2017)... 7D Surgical, developer of ground breaking surgical navigation ... Surgical System to support its strategic sales plan in ... and Virginia.  7D Surgical has entered into an exclusive sales ... medical facilities within those markets. ... Spartan Medical Purchases ...
    (Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
    Breaking Medicine Technology:
    (Date:8/16/2017)... ... August 16, 2017 , ... ... through affiliations and de novo development, today announced Cumberland Skin Surgery and ... Skin Surgery and Dermatology, with offices in both Hermitage and Lebanon, Tennessee, provides ...
    (Date:8/16/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, awarding him $1000 ... is in his third year at the University of California, Los Angeles majoring in ...
    (Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Fusion Flix ... premium original programming over four countries and millions of viewers in a partnership with ... rent or buy On-Demand and fully available on Blu Ray disc in 2018. Proceeds ...
    (Date:8/16/2017)... ... August 16, 2017 , ... ... new client win in the healthcare market, with Los Angeles-based AIDS Healthcare Foundation ... staff and members. , AHF cares for nearly 800,000 individuals worldwide and is ...
    (Date:8/16/2017)... ... 2017 , ... Rollon Skin Care Ltd., one ... announced the launch of two new skincare products, Prache Antiaging Cream and Prache ... plastic surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging Cream and Prache ...
    Breaking Medicine News(10 mins):